1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study. (2023), Bardeleb | AcademicGPT, tlooto

M-TEER with the fourth-generation M-TEer device was safe and effective at 1 year, with durable reductions in MR severity to ≤1+ in more than 90% of patients and concomitant improvements in functional (2023), JACC-Cardiovascular Interventions, Bardeleben R. V. von | AcademicGPT, tlooto for Academic and Research